JP2015527057A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015527057A5 JP2015527057A5 JP2015517896A JP2015517896A JP2015527057A5 JP 2015527057 A5 JP2015527057 A5 JP 2015527057A5 JP 2015517896 A JP2015517896 A JP 2015517896A JP 2015517896 A JP2015517896 A JP 2015517896A JP 2015527057 A5 JP2015527057 A5 JP 2015527057A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- constitutive
- genome
- cutoff value
- locus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 58
- 206010028980 Neoplasm Diseases 0.000 claims 18
- 108020004414 DNA Proteins 0.000 claims 16
- 239000012472 biological sample Substances 0.000 claims 12
- 201000011510 cancer Diseases 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 8
- 239000000523 sample Substances 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 230000035772 mutation Effects 0.000 claims 4
- 238000012163 sequencing technique Methods 0.000 claims 3
- 108091035707 Consensus sequence Proteins 0.000 claims 2
- 230000002601 intratumoral effect Effects 0.000 claims 2
- 238000005259 measurement Methods 0.000 claims 2
- 210000004881 tumor cell Anatomy 0.000 claims 2
- 108700028369 Alleles Proteins 0.000 claims 1
- 206010003445 Ascites Diseases 0.000 claims 1
- 208000006994 Precancerous Conditions Diseases 0.000 claims 1
- 210000003567 ascitic fluid Anatomy 0.000 claims 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 1
- 230000001973 epigenetic effect Effects 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 210000004910 pleural fluid Anatomy 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 210000001138 tear Anatomy 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018132118A JP6930948B2 (ja) | 2012-06-21 | 2018-07-12 | 癌検出のための血漿中ｄｎａの突然変異解析 |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261662878P | 2012-06-21 | 2012-06-21 | |
| US61/662,878 | 2012-06-21 | ||
| US201261682725P | 2012-08-13 | 2012-08-13 | |
| US61/682,725 | 2012-08-13 | ||
| US201261695795P | 2012-08-31 | 2012-08-31 | |
| US61/695,795 | 2012-08-31 | ||
| US201261711172P | 2012-10-08 | 2012-10-08 | |
| US61/711,172 | 2012-10-08 | ||
| US13/801,748 | 2013-03-13 | ||
| US13/801,748 US11261494B2 (en) | 2012-06-21 | 2013-03-13 | Method of measuring a fractional concentration of tumor DNA |
| PCT/IB2013/054898 WO2013190441A2 (en) | 2012-06-21 | 2013-06-14 | Mutational analysis of plasma dna for cancer detection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018132118A Division JP6930948B2 (ja) | 2012-06-21 | 2018-07-12 | 癌検出のための血漿中ｄｎａの突然変異解析 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015527057A JP2015527057A (ja) | 2015-09-17 |
| JP2015527057A5 true JP2015527057A5 (https=) | 2017-10-19 |
| JP6371280B2 JP6371280B2 (ja) | 2018-08-08 |
Family
ID=52274459
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015517896A Active JP6371280B2 (ja) | 2012-06-21 | 2013-06-14 | 癌検出のための血漿中ｄｎａの突然変異解析 |
| JP2018132118A Active JP6930948B2 (ja) | 2012-06-21 | 2018-07-12 | 癌検出のための血漿中ｄｎａの突然変異解析 |
| JP2021131682A Active JP7408161B2 (ja) | 2012-06-21 | 2021-08-12 | 癌検出のための血漿中ｄｎａの突然変異解析 |
| JP2023210140A Pending JP2024026360A (ja) | 2012-06-21 | 2023-12-13 | 癌検出のための血漿中ｄｎａの突然変異解析 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018132118A Active JP6930948B2 (ja) | 2012-06-21 | 2018-07-12 | 癌検出のための血漿中ｄｎａの突然変異解析 |
| JP2021131682A Active JP7408161B2 (ja) | 2012-06-21 | 2021-08-12 | 癌検出のための血漿中ｄｎａの突然変異解析 |
| JP2023210140A Pending JP2024026360A (ja) | 2012-06-21 | 2023-12-13 | 癌検出のための血漿中ｄｎａの突然変異解析 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US11261494B2 (https=) |
| EP (4) | EP3919627B1 (https=) |
| JP (4) | JP6371280B2 (https=) |
| KR (7) | KR102720785B1 (https=) |
| CN (3) | CN107779506B (https=) |
| AU (4) | AU2013278994C1 (https=) |
| CA (2) | CA3080937A1 (https=) |
| DK (2) | DK2864501T3 (https=) |
| EA (2) | EA037292B1 (https=) |
| ES (2) | ES2687847T3 (https=) |
| HU (1) | HUE056915T2 (https=) |
| IL (5) | IL298810B2 (https=) |
| MX (3) | MX360264B (https=) |
| PT (1) | PT3456843T (https=) |
| SG (2) | SG10201808217WA (https=) |
| TW (4) | TW202328458A (https=) |
| WO (1) | WO2013190441A2 (https=) |
| ZA (1) | ZA201409281B (https=) |
Families Citing this family (125)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| PL2557520T3 (pl) | 2007-07-23 | 2021-10-11 | The Chinese University Of Hong Kong | Określanie zaburzenia równowagi sekwencji kwasu nukleinowego |
| WO2010028288A2 (en) | 2008-09-05 | 2010-03-11 | Aueon, Inc. | Methods for stratifying and annotating cancer drug treatment options |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US12221653B2 (en) | 2010-05-18 | 2025-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12152275B2 (en) | 2010-05-18 | 2024-11-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| EP2619329B1 (en) | 2010-09-24 | 2019-05-22 | The Board of Trustees of The Leland Stanford Junior University | Direct capture, amplification and sequencing of target dna using immobilized primers |
| KR102759126B1 (ko) | 2010-12-30 | 2025-01-24 | 파운데이션 메디신 인코포레이티드 | 종양 샘플의 다유전자 분석의 최적화 |
| RU2671980C2 (ru) | 2011-02-09 | 2018-11-08 | Натера, Инк. | Способы неинвазивного пренатального установления плоидности |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| US11261494B2 (en) | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
| US20150011396A1 (en) | 2012-07-09 | 2015-01-08 | Benjamin G. Schroeder | Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| CN104781421B (zh) | 2012-09-04 | 2020-06-05 | 夸登特健康公司 | 检测稀有突变和拷贝数变异的系统和方法 |
| US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2014151117A1 (en) * | 2013-03-15 | 2014-09-25 | The Board Of Trustees Of The Leland Stanford Junior University | Identification and use of circulating nucleic acid tumor markers |
| US9822408B2 (en) | 2013-03-15 | 2017-11-21 | Nugen Technologies, Inc. | Sequential sequencing |
| WO2015073711A1 (en) | 2013-11-13 | 2015-05-21 | Nugen Technologies, Inc. | Compositions and methods for identification of a duplicate sequencing read |
| ES2660989T3 (es) | 2013-12-28 | 2018-03-27 | Guardant Health, Inc. | Métodos y sistemas para detectar variantes genéticas |
| US12492429B2 (en) * | 2014-04-21 | 2025-12-09 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| CA2945962C (en) * | 2014-04-21 | 2023-08-29 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| US20180173846A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
| TWI813141B (zh) | 2014-07-18 | 2023-08-21 | 香港中文大學 | Ｄｎａ混合物中之組織甲基化模式分析 |
| EP4358097A1 (en) * | 2014-07-25 | 2024-04-24 | University of Washington | Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same |
| CA2957633A1 (en) | 2014-08-06 | 2016-02-11 | Nugen Technologies, Inc. | Digital measurements from targeted sequencing |
| DK3198026T3 (da) * | 2014-08-07 | 2020-01-20 | Pharmassist Ltd | Fremgangsmåde til bestemmelse af pik3ca-mutationsstatus i en prøve |
| US12391985B2 (en) | 2014-08-07 | 2025-08-19 | Pharmassist Ltd | Method of determining PIK3CA mutational status in a sample |
| CN107075730A (zh) | 2014-09-12 | 2017-08-18 | 利兰·斯坦福青年大学托管委员会 | 循环核酸的鉴定及用途 |
| EP3227464B1 (en) * | 2014-12-05 | 2022-04-20 | Foundation Medicine, Inc. | Multigene analysis of tumor samples |
| EP3502273B1 (en) | 2014-12-12 | 2020-07-08 | Verinata Health, Inc. | Cell-free dna fragment |
| EP3766986B1 (en) * | 2014-12-31 | 2022-06-01 | Guardant Health, Inc. | Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results |
| US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
| HUE058263T2 (hu) | 2015-02-10 | 2022-07-28 | Univ Hong Kong Chinese | Mutációk detektálása rákszûrési és magzatelemzési célból |
| EP3288455B1 (en) * | 2015-05-01 | 2023-12-06 | Guardant Health, Inc. | Diagnostic methods |
| US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
| CN104894268B (zh) * | 2015-06-05 | 2018-02-09 | 上海美吉生物医药科技有限公司 | 定量样本中源自细胞凋亡的dna浓度的方法及其应用 |
| JP6202659B2 (ja) * | 2015-07-01 | 2017-09-27 | 学校法人慶應義塾 | 癌組織の不均一性マーカー及びその使用 |
| JP2017016665A (ja) * | 2015-07-03 | 2017-01-19 | 国立大学法人東北大学 | 配列のデータからの変異情報の選択方法、システム、及び、コンピュータプログラム |
| US10689706B2 (en) | 2015-07-20 | 2020-06-23 | The Chinese University Of Hong Kong | Methylation pattern analysis of haplotypes in tissues in a DNA mixture |
| IL305462A (en) | 2015-07-23 | 2023-10-01 | Univ Hong Kong Chinese | DNA fragmentation pattern analysis suitable clean |
| CA2995422A1 (en) * | 2015-08-12 | 2017-02-16 | The Chinese University Of Hong Kong | Single-molecule sequencing of plasma dna |
| AU2016310501B2 (en) | 2015-08-25 | 2019-11-07 | Nantomics, Llc | Systems and methods for genetic analysis of metastases |
| US12540351B2 (en) * | 2015-09-02 | 2026-02-03 | Guardant Health, Inc. | Identification of somatic mutations versus germline variants for cell-free DNA variant calling applications |
| SG11201805119QA (en) | 2015-12-17 | 2018-07-30 | Guardant Health Inc | Methods to determine tumor gene copy number by analysis of cell-free dna |
| CN116640847A (zh) * | 2016-02-02 | 2023-08-25 | 夸登特健康公司 | 癌症进化检测和诊断 |
| US10095831B2 (en) | 2016-02-03 | 2018-10-09 | Verinata Health, Inc. | Using cell-free DNA fragment size to determine copy number variations |
| KR101810528B1 (ko) * | 2016-03-29 | 2017-12-21 | 한국과학기술원 | 단백질을 변화시키지 않는 암 돌연변이의 기능적 recurrence를 구하는 방법 및 장치 |
| ES3002715T3 (en) * | 2016-04-14 | 2025-03-07 | Guardant Health Inc | Methods for early detection of cancer |
| RU2760913C2 (ru) | 2016-04-15 | 2021-12-01 | Натера, Инк. | Способы выявления рака легкого |
| EP3452937B1 (en) | 2016-05-01 | 2025-10-22 | Genome Research Limited | Method of characterising a dna sample |
| GB2555765A (en) * | 2016-05-01 | 2018-05-16 | Genome Res Ltd | Method of detecting a mutational signature in a sample |
| JP7224185B2 (ja) | 2016-05-01 | 2023-02-17 | ゲノム・リサーチ・リミテッド | Ｄｎａサンプルを特徴付ける方法 |
| CN105969656B (zh) * | 2016-05-13 | 2019-09-10 | 万康源(天津)基因科技有限公司 | 一种单细胞外显子测序肿瘤体细胞突变检测及分析平台 |
| CN105969856B (zh) * | 2016-05-13 | 2019-11-12 | 万康源(天津)基因科技有限公司 | 一种单细胞外显子测序肿瘤体细胞突变检测方法 |
| CN106355045B (zh) * | 2016-08-30 | 2019-03-15 | 天津诺禾致源生物信息科技有限公司 | 一种基于扩增子二代测序小片段插入缺失检测的方法及装置 |
| EP3461274B1 (en) * | 2016-09-30 | 2020-11-04 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| WO2018081130A1 (en) | 2016-10-24 | 2018-05-03 | The Chinese University Of Hong Kong | Methods and systems for tumor detection |
| GB201618485D0 (en) * | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
| WO2018090298A2 (en) * | 2016-11-17 | 2018-05-24 | Genomicare Biotechnology (Shanghai) Co. Ltd. | Systems and methods for monitoring lifelong tumor evolution |
| KR20260032575A (ko) | 2016-11-30 | 2026-03-09 | 더 차이니즈 유니버시티 오브 홍콩 | 소변 및 기타 샘플에서의 무세포 dna의 분석 |
| CN110383385B (zh) * | 2016-12-08 | 2023-07-25 | 生命科技股份有限公司 | 从肿瘤样品中检测突变负荷的方法 |
| CN106845153A (zh) * | 2016-12-29 | 2017-06-13 | 安诺优达基因科技(北京)有限公司 | 一种用于利用循环肿瘤dna样本检测体细胞突变的装置 |
| CN106874710A (zh) * | 2016-12-29 | 2017-06-20 | 安诺优达基因科技(北京)有限公司 | 一种用于利用肿瘤ffpe样本检测体细胞突变的装置 |
| SG11201906397UA (en) | 2017-01-25 | 2019-08-27 | Univ Hong Kong Chinese | Diagnostic applications using nucleic acid fragments |
| US12492430B2 (en) | 2017-04-11 | 2025-12-09 | Tecan Genomics, Inc. | Library quantitation and qualification |
| US11342047B2 (en) * | 2017-04-21 | 2022-05-24 | Illumina, Inc. | Using cell-free DNA fragment size to detect tumor-associated variant |
| CN110914450B (zh) * | 2017-05-16 | 2024-07-02 | 夸登特健康公司 | 无细胞dna的体细胞来源或种系来源的鉴定 |
| KR102145417B1 (ko) * | 2017-05-24 | 2020-08-19 | 지니너스 주식회사 | 무세포 핵산으로부터 수득된 서열 분석 데이터에 대한 배경 대립인자의 빈도 분포를 생성하는 방법 및 이를 이용하여 무세포 핵산으로부터 변이를 검출하는 방법 |
| CN111051536A (zh) | 2017-07-26 | 2020-04-21 | 香港中文大学 | 利用不含细胞的病毒核酸改善癌症筛选 |
| EP3682035B1 (en) * | 2017-09-15 | 2025-02-05 | The Regents of the University of California | Detecting somatic single nucleotide variants from cell-free nucleic acid with application to minimal residual disease monitoring |
| CA3075932A1 (en) * | 2017-09-20 | 2019-03-28 | Guardant Health, Inc. | Methods and systems for differentiating somatic and germline variants |
| AU2018348074A1 (en) * | 2017-10-10 | 2020-04-16 | Nantomics, Llc | Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with cancer |
| US11099202B2 (en) | 2017-10-20 | 2021-08-24 | Tecan Genomics, Inc. | Reagent delivery system |
| WO2019090156A1 (en) * | 2017-11-03 | 2019-05-09 | Guardant Health, Inc. | Normalizing tumor mutation burden |
| CN110870016B (zh) * | 2017-11-30 | 2024-09-06 | 伊鲁米那股份有限公司 | 用于序列变体呼出的验证方法和系统 |
| US12084720B2 (en) | 2017-12-14 | 2024-09-10 | Natera, Inc. | Assessing graft suitability for transplantation |
| US20190249229A1 (en) * | 2018-02-12 | 2019-08-15 | Nant Holdings Ip, Llc | Bam signatures from liquid and solid tumors and uses therefor |
| US12024738B2 (en) | 2018-04-14 | 2024-07-02 | Natera, Inc. | Methods for cancer detection and monitoring |
| WO2019204360A1 (en) * | 2018-04-16 | 2019-10-24 | Grail, Inc. | Systems and methods for determining tumor fraction in cell-free nucleic acid |
| AU2019277698A1 (en) | 2018-06-01 | 2020-11-19 | Grail, Llc | Convolutional neural network systems and methods for data classification |
| WO2019236478A1 (en) * | 2018-06-04 | 2019-12-12 | Guardant Health, Inc. | Methods and systems for determining the cellular origin of cell-free nucleic acids |
| BR112020024727A2 (pt) | 2018-06-11 | 2021-03-23 | Foundation Medicine, Inc. | composições e métodos para avaliação de alterações genômicas |
| US12234509B2 (en) | 2018-07-03 | 2025-02-25 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| WO2020023420A2 (en) * | 2018-07-23 | 2020-01-30 | Guardant Health, Inc. | Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage |
| BR112020026259A2 (pt) * | 2018-11-01 | 2021-07-27 | Illumina, Inc. | métodos e composições para detecção de variante de linhagem germinativa |
| JP7499239B2 (ja) * | 2018-11-13 | 2024-06-13 | ミリアド・ジェネティックス・インコーポレイテッド | 体細胞変異のための方法およびシステム、ならびにそれらの使用 |
| US11581062B2 (en) | 2018-12-10 | 2023-02-14 | Grail, Llc | Systems and methods for classifying patients with respect to multiple cancer classes |
| CN113366122B (zh) | 2018-12-19 | 2024-01-12 | 香港中文大学 | 游离dna末端特征 |
| US20200219587A1 (en) * | 2018-12-21 | 2020-07-09 | Grail, Inc. | Systems and methods for using fragment lengths as a predictor of cancer |
| CN109616198A (zh) * | 2018-12-28 | 2019-04-12 | 陈洪亮 | 仅用于肝癌单一癌种筛查的特异甲基化检测位点组合的选取方法 |
| CN109686414A (zh) * | 2018-12-28 | 2019-04-26 | 陈洪亮 | 仅用于肝癌筛查的特异甲基化检测位点组合的选取方法 |
| CN109817279B (zh) * | 2019-01-18 | 2022-11-04 | 臻悦生物科技江苏有限公司 | 肿瘤突变负荷的检测方法、装置、存储介质及处理器 |
| KR102381252B1 (ko) * | 2019-02-19 | 2022-04-01 | 주식회사 녹십자지놈 | 혈중 무세포 dna 기반 간암 치료 예후예측 방법 |
| CN109841265B (zh) * | 2019-02-22 | 2021-09-21 | 清华大学 | 使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用 |
| CN109920480B (zh) * | 2019-03-14 | 2020-02-21 | 深圳市海普洛斯生物科技有限公司 | 一种校正高通量测序数据的方法和装置 |
| CN111755075B (zh) * | 2019-03-28 | 2023-09-29 | 深圳华大生命科学研究院 | 对免疫组库高通量测序样本间序列污染进行过滤的方法 |
| US12497662B2 (en) | 2019-04-16 | 2025-12-16 | Grail, Inc. | Systems and methods for tumor fraction estimation from small variants |
| US12437839B2 (en) | 2019-05-03 | 2025-10-07 | Ultima Genomics, Inc. | Methods for detecting nucleic acid variants |
| CN120412737A (zh) | 2019-05-03 | 2025-08-01 | 阿尔缇玛基因组学公司 | 用于检测核酸变体的方法 |
| CA3139535A1 (en) * | 2019-05-17 | 2020-11-26 | Ultima Genomics, Inc. | Methods and systems for detecting residual disease |
| CN114026646A (zh) * | 2019-05-20 | 2022-02-08 | 基金会医学公司 | 用于评估肿瘤分数的系统和方法 |
| CN111223525A (zh) * | 2020-01-07 | 2020-06-02 | 广州基迪奥生物科技有限公司 | 一种肿瘤外显子测序数据分析方法 |
| EP3851542A1 (en) | 2020-01-20 | 2021-07-21 | Tecan Genomics, Inc. | Depletion of abundant uninformative sequences |
| US12059674B2 (en) | 2020-02-03 | 2024-08-13 | Tecan Genomics, Inc. | Reagent storage system |
| US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
| US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
| US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
| CN117063239A (zh) * | 2021-03-05 | 2023-11-14 | 夸登特健康公司 | 用于分析分子响应的方法和相关方面 |
| JP7022861B1 (ja) * | 2021-06-25 | 2022-02-18 | 株式会社日立パワーソリューションズ | アレイ型超音波送受信装置 |
| CA3224461A1 (en) * | 2021-06-30 | 2023-01-05 | Jonathan Chee Ming WAN | Detection of somatic mutational signatures from whole genome sequencing of cell-free dna |
| CN114242172B (zh) * | 2021-07-12 | 2025-04-25 | 广州燃石医学检验所有限公司 | 基于血液测序的肿瘤内异质性的评估方法及其用于预测免疫疗法的应答 |
| KR102935486B1 (ko) * | 2021-12-06 | 2026-03-10 | 주식회사 지씨지놈 | 혈중 무세포 dna 기반 유방암 치료 예후예측 방법 |
| CN115064212B (zh) * | 2022-06-24 | 2023-03-14 | 哈尔滨星云生物信息技术开发有限公司 | 基于wgs数据的预设区域人群肿瘤特异突变识别方法 |
| EP4547869A1 (en) | 2022-06-29 | 2025-05-07 | Raman Govindarajan | Method for detecting cancer susceptibility, early detection and predicting cancer behaviour |
| KR102923761B1 (ko) * | 2022-10-13 | 2026-02-04 | 인하대학교 산학협력단 | cfDNA의 구조 변이 서열 검출을 통한 미세잔존질환 진단 방법 |
| CN117012274B (zh) * | 2023-10-07 | 2024-01-16 | 北京智因东方转化医学研究中心有限公司 | 基于高通量测序识别基因缺失的装置 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA005140B1 (ru) | 1999-04-02 | 2004-12-30 | Корикса Корпорейшн | Соединения и способы для лечения и диагностики рака легкого |
| US20030219765A1 (en) | 2000-03-23 | 2003-11-27 | Jose Costa | Methods for evaluating cancer risk |
| US20030211522A1 (en) | 2002-01-18 | 2003-11-13 | Landes Gregory M. | Methods for fetal DNA detection and allele quantitation |
| EP1509619B1 (en) | 2002-05-10 | 2012-04-04 | City of Hope | Pyrophosphorolysis activated polymerization (pap) |
| US7704687B2 (en) | 2002-11-15 | 2010-04-27 | The Johns Hopkins University | Digital karyotyping |
| US20060188889A1 (en) * | 2003-11-04 | 2006-08-24 | Christopher Burgess | Use of differentially expressed nucleic acid sequences as biomarkers for cancer |
| EP1599608A4 (en) | 2003-03-05 | 2007-07-18 | Genetic Technologies Ltd | Identification of fetal DNA and fetal cell marker in maternal plasma or serum |
| PL201608B1 (pl) | 2003-06-13 | 2009-04-30 | Cezary Cybulski | Sposób i zestaw do wykrywania wysokiej genetycznie uwarunkowanej predyspozycji do raka prostaty oraz zastosowanie zmiany germinalnej w obrębie genu NBS1 |
| ATE435301T1 (de) | 2003-10-16 | 2009-07-15 | Sequenom Inc | Nicht invasiver nachweis fötaler genetischer merkmale |
| WO2005108621A1 (en) | 2004-04-30 | 2005-11-17 | Yale University | Methods and compositions for cancer diagnosis |
| US7645576B2 (en) * | 2005-03-18 | 2010-01-12 | The Chinese University Of Hong Kong | Method for the detection of chromosomal aneuploidies |
| US20070122823A1 (en) | 2005-09-01 | 2007-05-31 | Bianchi Diana W | Amniotic fluid cell-free fetal DNA fragment size pattern for prenatal diagnosis |
| EP3591068A1 (en) | 2006-02-02 | 2020-01-08 | The Board of Trustees of the Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
| EP2351858B1 (en) | 2006-02-28 | 2014-12-31 | University of Louisville Research Foundation | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
| WO2008024009A1 (en) | 2006-08-15 | 2008-02-28 | Institut Molekulyarnoi Genetiki Rossiiskoi Akademii Nauk (Img Ran) | Transcriptional level of a timp3 gene in the form of a diagnosis marker of a non-small cell carcinoma of lung |
| JP2010527603A (ja) | 2007-05-25 | 2010-08-19 | ディコーデ ジェネテクス イーエイチエフ | 乳癌のリスクアセスメント、診断、予後診断および治療における使用のためのマーカーとしてのＣＨＲ５ｐ１２および１０ｑ２６上の遺伝的変異 |
| PL2557520T3 (pl) * | 2007-07-23 | 2021-10-11 | The Chinese University Of Hong Kong | Określanie zaburzenia równowagi sekwencji kwasu nukleinowego |
| US20090053719A1 (en) | 2007-08-03 | 2009-02-26 | The Chinese University Of Hong Kong | Analysis of nucleic acids by digital pcr |
| WO2009051842A2 (en) * | 2007-10-18 | 2009-04-23 | The Johns Hopkins University | Detection of cancer by measuring genomic copy number and strand length in cell-free dna |
| US20100041048A1 (en) | 2008-07-31 | 2010-02-18 | The Johns Hopkins University | Circulating Mutant DNA to Assess Tumor Dynamics |
| CA3069082C (en) * | 2008-09-20 | 2022-03-22 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
| WO2010053980A2 (en) * | 2008-11-04 | 2010-05-14 | The Johns Hopkins University | Dna integrity assay (dia) for cancer diagnostics, using confocal fluorescence spectroscopy |
| US20100136560A1 (en) | 2008-12-02 | 2010-06-03 | The Johns Hopkins University | Integrated Analyses of Breast and Colorectal Cancers |
| WO2010091046A2 (en) * | 2009-02-03 | 2010-08-12 | President & Fellows Of Harvard College | Systems and methods for high throughput, high fidelity, single molecule nucleic acid sequencing using time multiplexed excitation |
| US20120021428A1 (en) | 2009-03-31 | 2012-01-26 | Marcus Otte | Method for diagnosis of cancer and monitoring of cancer treatments |
| US20120208711A1 (en) | 2009-10-02 | 2012-08-16 | Centre For Addiction And Mental Health | Method for Analysis of DNA Methylation Profiles of Cell-Free Circulating DNA in Bodily Fluids |
| WO2011053790A2 (en) | 2009-10-30 | 2011-05-05 | Fluidigm Corporation | Assay of closely linked targets in fetal diagnosis and coincidence detection assay for genetic analysis |
| EP3783110B1 (en) | 2009-11-05 | 2022-11-23 | The Chinese University Of Hong Kong | Fetal genomic analysis from a maternal biological sample |
| CA2780016C (en) | 2009-11-06 | 2017-09-19 | The Chinese University Of Hong Kong | Size-based genomic analysis |
| GB0922006D0 (en) | 2009-12-17 | 2010-02-03 | Genome Res Ltd | Diagnostic |
| EP2513341B1 (en) | 2010-01-19 | 2017-04-12 | Verinata Health, Inc | Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing |
| EP2370599B1 (en) | 2010-01-19 | 2015-01-21 | Verinata Health, Inc | Method for determining copy number variations |
| WO2011103236A2 (en) | 2010-02-18 | 2011-08-25 | The Johns Hopkins University | Personalized tumor biomarkers |
| EP2426217A1 (en) | 2010-09-03 | 2012-03-07 | Centre National de la Recherche Scientifique (CNRS) | Analytical methods for cell free nucleic acids and applications |
| CN105243295B (zh) | 2010-11-30 | 2018-08-17 | 香港中文大学 | 与癌症相关的遗传或分子畸变的检测 |
| AU2011373694A1 (en) | 2011-07-26 | 2013-05-02 | Verinata Health, Inc. | Method for determining the presence or absence of different aneuploidies in a sample |
| JP6073902B2 (ja) | 2011-10-06 | 2017-02-01 | セクエノム， インコーポレイテッド | 遺伝的変異の非侵襲的評価のための方法およびプロセス |
| WO2013060762A1 (en) * | 2011-10-25 | 2013-05-02 | Roche Diagnostics Gmbh | Method for diagnosing a disease based on plasma-dna distribution |
| WO2013086352A1 (en) | 2011-12-07 | 2013-06-13 | Chronix Biomedical | Prostate cancer associated circulating nucleic acid biomarkers |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| WO2013138510A1 (en) | 2012-03-13 | 2013-09-19 | Patel Abhijit Ajit | Measurement of nucleic acid variants using highly-multiplexed error-suppressed deep sequencing |
| US11261494B2 (en) | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
| CN104781421B (zh) | 2012-09-04 | 2020-06-05 | 夸登特健康公司 | 检测稀有突变和拷贝数变异的系统和方法 |
| EP2959016A4 (en) | 2013-02-21 | 2016-10-12 | Toma Biosciences Inc | METHOD, COMPOSITIONS AND NUCLEIC ACID ANALYSIS KITS |
| WO2014145078A1 (en) | 2013-03-15 | 2014-09-18 | Verinata Health, Inc. | Generating cell-free dna libraries directly from blood |
| US10174375B2 (en) | 2013-09-20 | 2019-01-08 | The Chinese University Of Hong Kong | Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases |
| US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
| EP4358097A1 (en) | 2014-07-25 | 2024-04-24 | University of Washington | Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same |
-
2013
- 2013-03-13 US US13/801,748 patent/US11261494B2/en active Active
- 2013-06-14 EP EP21185002.9A patent/EP3919627B1/en active Active
- 2013-06-14 SG SG10201808217WA patent/SG10201808217WA/en unknown
- 2013-06-14 CA CA3080937A patent/CA3080937A1/en active Pending
- 2013-06-14 IL IL298810A patent/IL298810B2/en unknown
- 2013-06-14 PT PT18185290T patent/PT3456843T/pt unknown
- 2013-06-14 CA CA2876327A patent/CA2876327C/en active Active
- 2013-06-14 KR KR1020247011005A patent/KR102720785B1/ko active Active
- 2013-06-14 EA EA201500027A patent/EA037292B1/ru unknown
- 2013-06-14 IL IL311127A patent/IL311127B2/en unknown
- 2013-06-14 JP JP2015517896A patent/JP6371280B2/ja active Active
- 2013-06-14 EP EP18185290.6A patent/EP3456843B1/en active Active
- 2013-06-14 ES ES13807105.5T patent/ES2687847T3/es active Active
- 2013-06-14 HU HUE18185290A patent/HUE056915T2/hu unknown
- 2013-06-14 SG SG11201408113QA patent/SG11201408113QA/en unknown
- 2013-06-14 KR KR1020227008276A patent/KR102521842B1/ko active Active
- 2013-06-14 EP EP13807105.5A patent/EP2864501B1/en active Active
- 2013-06-14 CN CN201711070698.4A patent/CN107779506B/zh active Active
- 2013-06-14 DK DK13807105.5T patent/DK2864501T3/en active
- 2013-06-14 CN CN201380042981.XA patent/CN104662168B/zh active Active
- 2013-06-14 KR KR1020217009799A patent/KR102375645B1/ko active Active
- 2013-06-14 EP EP24201699.6A patent/EP4512907A3/en active Pending
- 2013-06-14 KR KR1020207009028A patent/KR102237923B1/ko active Active
- 2013-06-14 WO PCT/IB2013/054898 patent/WO2013190441A2/en not_active Ceased
- 2013-06-14 KR KR1020157001225A patent/KR101884909B1/ko active Active
- 2013-06-14 KR KR1020187021883A patent/KR102096611B1/ko active Active
- 2013-06-14 ES ES18185290T patent/ES2894479T3/es active Active
- 2013-06-14 AU AU2013278994A patent/AU2013278994C1/en active Active
- 2013-06-14 MX MX2014016058A patent/MX360264B/es active IP Right Grant
- 2013-06-14 CN CN202110493949.XA patent/CN113151474A/zh active Pending
- 2013-06-14 EA EA202092900A patent/EA202092900A3/ru unknown
- 2013-06-14 KR KR1020237012164A patent/KR102656030B1/ko active Active
- 2013-06-14 DK DK18185290.6T patent/DK3456843T3/da active
- 2013-06-20 TW TW111143054A patent/TW202328458A/zh unknown
- 2013-06-20 TW TW102122036A patent/TWI636255B/zh active
- 2013-06-20 TW TW107128593A patent/TWI803505B/zh active
- 2013-06-20 TW TW109127987A patent/TWI786428B/zh active
-
2014
- 2014-11-27 IL IL235967A patent/IL235967B/en active IP Right Grant
- 2014-12-17 ZA ZA2014/09281A patent/ZA201409281B/en unknown
- 2014-12-19 MX MX2023001154A patent/MX2023001154A/es unknown
- 2014-12-19 MX MX2018013085A patent/MX2018013085A/es unknown
-
2017
- 2017-07-04 AU AU2017204558A patent/AU2017204558B2/en active Active
- 2017-12-22 US US15/853,288 patent/US20180202003A1/en active Pending
-
2018
- 2018-07-12 JP JP2018132118A patent/JP6930948B2/ja active Active
-
2019
- 2019-05-08 US US16/406,715 patent/US20190264291A1/en not_active Abandoned
- 2019-08-12 IL IL26864519A patent/IL268645A/en active IP Right Grant
-
2020
- 2020-01-08 AU AU2020200122A patent/AU2020200122B2/en active Active
- 2020-11-19 IL IL278867A patent/IL278867B2/en unknown
-
2021
- 2021-08-12 JP JP2021131682A patent/JP7408161B2/ja active Active
-
2022
- 2022-07-28 AU AU2022209294A patent/AU2022209294A1/en not_active Abandoned
-
2023
- 2023-12-13 JP JP2023210140A patent/JP2024026360A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015527057A5 (https=) | ||
| AU2023219906A1 (en) | Using size and number aberrations in plasma DNA for detecting cancer | |
| DK2823062T5 (en) | SIZE-BASED ANALYSIS OF Fetal DNA FRACTION IN MOTHER PLASMA | |
| IL311127B2 (en) | Mutational analysis of plasma DNA for cancer detection | |
| CN107423534B (zh) | 基因组拷贝数变异的检测方法和系统 | |
| JP2015510757A5 (https=) | ||
| CN106676178B (zh) | 一种评估肿瘤异质性的方法及系统 | |
| JP2015536639A5 (https=) | ||
| EP3518974A1 (en) | Noninvasive prenatal screening using dynamic iterative depth optimization | |
| Samad et al. | Imputation-based population genetics analysis of Plasmodium falciparum malaria parasites | |
| Liu et al. | Personalised pathway analysis reveals association between DNA repair pathway dysregulation and chromosomal instability in sporadic breast cancer | |
| CN116348957A (zh) | 检测测序数据中的交叉污染 | |
| JP2025509878A (ja) | 処置モニタリングのためのメチル化セルフリーｄｎａの分子計数 | |
| JP7332695B2 (ja) | 循環核酸からの全ゲノム配列データにおける包括的配列特徴の同定 | |
| JP6571526B2 (ja) | 鎖を除外することによりマイクロアレイの性能を向上する方法 | |
| KR20130125617A (ko) | 비정상 조직의 유전 정보를 분석하는 방법 및 장치 | |
| CN105316223A (zh) | 生物学样品分析系统及方法 | |
| Walter et al. | Accuracy of p53 codon 72 polymorphism status determined by multiple laboratory methods: a latent class model analysis | |
| US8255167B2 (en) | Non-hypergeometric overlap probability | |
| CN115762635A (zh) | 基于分子标记的用于肝癌筛查和风险预测的系统及应用 | |
| CN118355131A (zh) | 用于预测疾病复发的病毒dna测序 | |
| Grossman et al. | Evaluating the Cost of Genomic Testing for Biomarker-Driven Therapies in Oncology | |
| Shi et al. | Gimscan: A new statistical method for analyzing whole-genome array cgh data | |
| CN117953967A (zh) | 一种评估肿瘤纯度的方法、校正tmb的方法及设备 | |
| Arroyo-Mühr et al. | No measurable substitution rate in the HPV16 genome in women with subsequent in situ or invasive cervical cancer: prospective population-based study |